東勝創(chuàng)新攜手Fluidigm開啟單細(xì)胞技術(shù)巡回講座

瀏覽次數(shù)：5615　發(fā)布日期：2014-9-30　來源：本站　本站原創(chuàng)，轉(zhuǎn)載請(qǐng)注明出處

The Biography of the two speakers are as follows:

Xiangxu Kong （孔祥旭），Ph.D

Now Doctor Kong is the single cell biology specialist of Fluidigm, working closely with customers in Pacific Asia and Latin America, very experienced in single-cell related research and diagnostics.

Dongxia Lin, Ph.D

Doctor Lin Dongxia is currently a Postdoctoral Research Scholar in Human Immune Monitoring Center at Stanford Univeristy. Lin is in the lab which has the Second and 22nd CyTOF of the world. In the past 3-years, Lin is working on many frontier fields with CyTOF mass cytometry. Using this cutting-edge multi-parameter single-cell technology, she has successfully finished three major projects, including biomarker prediction for autoimmune disease treatment; influenza vaccine efficacy evaluation and antigen specific T cell response in transplant patients. These results were published in several well-known journals and presented on international conferences in Cold Spring Harbor, Hawaii and Canada before.

本次單細(xì)胞技術(shù)巡回講座首站將在上海舉行，陸續(xù)會(huì)在北京，蘇州等城市展開，活動(dòng)通知及時(shí)更新，屆時(shí)期待您的光臨指導(dǎo)！

欲知更多詳情，請(qǐng)通過以下方式聯(lián)系我們：